People travel from across the country and around the world for Blood and Marrow Transplant (BMT) treatment at our hospitals. University of Minnesota Medical Center and University of Minnesota Masonic Children's Hospital have provided compassionate, expert, innovative care to blood and marrow transplant (BMT) patients for over 40 years.
Our program has been at the forefront of advances since performing the world's first successful BMT in 1968. Our teams have performed more than 6,000 BMTs since that time.
Driving research to reality
Our BMT Program continues to thrive as one of the most respected BMT research and treatment programs in the world. Here’s why:
Check out our historical timeline of important milestones in blood and marrow transplant at the University of Minnesota and University of Minnesota Medical Center.
We offer the highest-quality treatment and care based on your specific circumstances and needs.
Our first-rate researchers are committed to turning what they learn through research into successful treatment options.
We have the largest umbilical cord blood program in the country, making BMT a realistic option for more patients than ever before.
In 2005, our researchers were the first to report the success of using a unique type of donor cells for treatment of an advanced type of leukemia. They used Natural Killer (NK) cells to successfully treat advanced acute myelogenous leukemia (AML).
We offer you a patient- and-family-centered care approach to provide high-quality, compassionate care.
We continually strive to improve the safety and effectiveness of transplant therapy, to provide you and all our patients with the best possible outcomes.